"Immunomodulation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Alteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. Immunomodulation can also encompass non-therapeutic alteration of the immune system effected by endogenous or exogenous substances.
| Descriptor ID |
D056747
|
| MeSH Number(s) |
E02.095.465 G12.535
|
| Concept/Terms |
Immunomodulation- Immunomodulation
- Immunomodulations
- Immunomodulatory Therapy
- Immunomodulatory Therapies
- Therapies, Immunomodulatory
- Therapy, Immunomodulatory
|
Below are MeSH descriptors whose meaning is more general than "Immunomodulation".
Below are MeSH descriptors whose meaning is more specific than "Immunomodulation".
This graph shows the total number of publications written about "Immunomodulation" by people in this website by year, and whether "Immunomodulation" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 3 | 6 | 9 |
| 2011 | 2 | 11 | 13 |
| 2012 | 9 | 8 | 17 |
| 2013 | 2 | 15 | 17 |
| 2014 | 3 | 12 | 15 |
| 2015 | 3 | 18 | 21 |
| 2016 | 13 | 17 | 30 |
| 2017 | 9 | 17 | 26 |
| 2018 | 9 | 9 | 18 |
| 2019 | 15 | 11 | 26 |
| 2020 | 9 | 8 | 17 |
| 2021 | 8 | 16 | 24 |
| 2022 | 1 | 3 | 4 |
| 2023 | 1 | 4 | 5 |
| 2024 | 0 | 7 | 7 |
Below are the most recent publications written about "Immunomodulation" by people in Profiles.
-
Exploring Molecular Drivers of PARPi Resistance in BRCA1-Deficient Ovarian Cancer: The Role of LY6E and Immunomodulation. Int J Mol Sci. 2024 Sep 27; 25(19).
-
Local complement activation and modulation in mucosal immunity. Mucosal Immunol. 2024 Aug; 17(4):739-751.
-
An updated management approach of Pompe disease patients with high-sustained anti-rhGAA IgG antibody titers: experience with bortezomib-based immunomodulation. Front Immunol. 2024; 15:1360369.
-
The Complexity of Being A20: From Biological Functions to Genetic Associations. J Clin Immunol. 2024 03 07; 44(3):76.
-
Immunomodulatory Response of the Middle Ear Epithelial Cells in Otitis Media. Otol Neurotol. 2024 Mar 01; 45(3):e248-e255.
-
Case report: Approaches to treatment-refractory and super-refractory glutamic acid decarboxylase antibody-spectrum disorders. Front Immunol. 2023; 14:1297340.
-
Choosing immunomodulating therapies for the treatment of COVID-19: recommendations based on placebo-controlled trial evidence. Clin Microbiol Infect. 2024 May; 30(5):611-618.
-
Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation. J Hepatol. 2023 06; 78(6):1199-1215.
-
Does congenital cytomegalovirus infection contribute to the development of acute lymphoblastic leukemia in children? Curr Opin Virol. 2023 06; 60:101325.
-
Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus. Nature. 2023 04; 616(7958):798-805.